Hemophilia A

(Redirected from Hemophilia)
Jump to: navigation, search
Hemophilia A
ICD-10 D66.
ICD-9 286.0
OMIM 306700
DiseasesDB 5555
MedlinePlus 000538
MeSH D006467

Hemophilia A Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophilia A from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia A On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophilia A

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia A

CDC on Hemophilia A

Hemophilia A in the news

Blogs on Hemophilia A</small>

Directions to Hospitals Treating Hemophilia A

Risk calculators and risk factors for Hemophilia A

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahd Yunus, M.D. [2]

Synonyms and Keywords: Haemophilia A; Hæmophilia A; Factor VIII deficiency, Classic Hemophilia

Overview

Hemophilia A is a disease characterized by a genetic deficiency in clotting Factor VIII, which results in excessive bleeding.

Historical Perspective

Classification

Pathophysiology

Differentiating Hemophilia A from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters


it:Emofilia

Linked-in.jpg